Drug Information

Drug General Information
Drug ID
D09GIA
Former ID
DNCL003736
Drug Name
SAR391786
Drug Type
Antibody
Indication Muscle atrophy [ICD10:M62.5] Phase 2 [524475]
Company
Sanofi
Target and Pathway
Target(s) Growth/differentiation factor 8 Target Info [530761]
PANTHER Pathway TGF-beta signaling pathway
WikiPathways Hypertrophy Model
References
Ref 524475ClinicalTrials.gov (NCT01963598) Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia. U.S. National Institutes of Health.
Ref 530761Myostatin (GDF-8) as a key factor linking muscle mass and bone structure. J Musculoskelet Neuronal Interact. 2010 Mar;10(1):56-63.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.